World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
39251
World Ranking
6047
National Ranking
3233

Overview

Donald C. Goff is affiliated with New York University in the United States and has contributed extensively to the field of medicine, with a focus on psychiatry and mental health. Their research spans several key areas within medicine, contributing notably to topics associated with schizophrenia and COVID-19.

Their recent scholarly works include:

  • Association of Psychiatric Disorders With Mortality Among Patients With COVID-19 (2021, JAMA Psychiatry)
  • Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries (2021, JAMA Psychiatry)
  • Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice (2020, The Journal of Clinical Psychiatry)
  • Psychiatry and COVID-19 (2020, JAMA)
  • The Pharmacologic Treatment of Schizophrenia-2021 (2020, JAMA)

The main fields and subfields of study associated with Donald C. Goff include:

  • Medicine
  • Radiology, Nuclear Medicine and Imaging
  • Psychiatry and Mental Health
  • Cognitive Neuroscience
  • Neurology
  • Biological Psychiatry

Among the primary topics of investigation in their work are:

  • Schizophrenia research and treatment
  • Advanced Neuroimaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Advanced MRI Techniques and Applications
  • Tryptophan and brain disorders
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health

Donald C. Goff has published across several frequent venues, including:

  • JAMA
  • Biological Psychiatry
  • Schizophrenia Research
  • UNC Libraries
  • Schizophrenia Bulletin

The scientist has collaborated with various co-authors such as Michael Berkwits, Mary Mcdermott, Jody Zylke, Annette Flanagin, and a Managing Editor, each listed as frequent collaborators.

Best Publications

  • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

    Joseph Patrick McEvoy;Jonathan M. Meyer;Donald C. Goff;Henry A. Nasrallah

  • The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia

    Donald C. Goff;Joseph T. Coyle

  • Regionally Localized Thinning of the Cerebral Cortex in Schizophrenia

    Gina R. Kuperberg;Matthew R. Broome;Philip K. McGuire;Anthony S. David

  • Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study

    David C. Henderson;Enrico Cagliero;Colin Gray;Rima A. Nasrallah

  • Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects.

    Donald C. Goff;David C. Henderson;Edward Amico

  • Impaired recruitment of the hippocampus during conscious recollection in schizophrenia.

    Stephan Heckers;Scott L. Rauch;Donald Goff;Cary R. Savage

  • Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.

    Henry A. Nasrallah;Jonathan M. Meyer;Donald C. Goff;Joseph Patrick McEvoy

  • A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

    Donald C. Goff;Lisa M. Sullivan;Joseph Patrick McEvoy;Jonathan M. Meyer

  • Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

    Dara S Manoach;Randy L Gollub;Etienne S Benson;Meghan M Searl

  • A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia

    Robert W Buchanan;Miriam Davis;Donald Goff;Michael F Green

  • Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

    Joseph T. Coyle;Joseph T. Coyle;Guochuan Tsai;Guochuan Tsai;Donald Goff

  • Reduced Sleep Spindles and Spindle Coherence in Schizophrenia: Mechanisms of Impaired Memory Consolidation?

    Erin J. Wamsley;Matthew A. Tucker;Ann K. Shinn;Kim E. Ono

  • Cognitive therapy for psychosis in schizophrenia: an effect size analysis.

    Robert A. Gould;Kim T. Mueser;Elisa Bolton;Virgina Mays

  • A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

    Donald C. Goff;Guochuan Tsai;James Levitt;Edward Amico

  • Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI

    Dara S. Manoach;Daniel Z Press;Venkatassen Thangaraj;Meghan M Searl

  • Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

    David C. Henderson;Enrico Cagliero;Paul M. Copeland;Christina P. Borba

  • Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists

    Donald C. Goff;Corinne Cather;A. Eden Evins;David C. Henderson

  • Change in Metabolic Syndrome Parameters With Antipsychotic Treatment in the CATIE Schizophrenia Trial: Prospective Data From Phase 1

    Jonathan M. Meyer;Jonathan M. Meyer;Vicki G. Davis;Donald C. Goff;Joseph Patrick McEvoy

  • Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

    D. C. Goff;Guochan Tsai;D. R. Manoach;J. T. Coyle

  • Regionally localized thinning of the cerebral cortex in schizophrenia

    G.R. Kuperberg;M. Broome;P.K. McGuire;A.S. David

Frequent Co-Authors

Dara S. Manoach
Dara S. Manoach Harvard University
Corinne Cather
Corinne Cather Harvard University
Joshua L. Roffman
Joshua L. Roffman Harvard University
Stephan Heckers
Stephan Heckers Vanderbilt University Medical Center
Jeffrey A. Lieberman
Jeffrey A. Lieberman Columbia University
Joseph P. McEvoy
Joseph P. McEvoy Augusta University
Christina P.C. Borba
Christina P.C. Borba Boston University
Gina R. Kuperberg
Gina R. Kuperberg Tufts University
Scott L. Rauch
Scott L. Rauch McLean Hospital
Thilo Deckersbach
Thilo Deckersbach Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional MD programs, there are several flexible and affordable online pathways to explore. Nursing is one of the most popular options, and students often look for affordable nursing programs that suit their budget and schedule without sacrificing quality.

Aspiring nurse leaders and educators may consider the cheapest dnp online program, which prepares graduates for advanced practice and high-level roles. For registered nurses aiming to further their education, the most affordable accredited online rn to bsn programs offer a convenient way to earn a bachelor’s degree while working.

If you don’t have a nursing background but wish to enter the field quickly, the direct entry msn online route can fast-track you toward becoming a registered nurse or nurse leader. With these diverse online options, pursuing a healthcare career is more accessible than ever—no matter where you’re starting from.

Best Scientists Citing Donald C. Goff

Trending Scientists

Recently Published Articles